NASDAQ: AVLNRUSSELL2000
Avalyn Pharma Inc. Common Stock
Healthcare · Medical - Pharmaceuticals · Headquartered in Boston, US
Price
Loading chart…
Overview
Avalyn Pharma Inc. operates as a biopharmaceutical firm currently in its clinical development phase. The company's primary focus is on creating inhaled pharmaceutical products to manage rare lung conditions, including pulmonary fibrosis and various other interstitial lung diseases (ILDs). Richard Glenn Vincent, Mark W. Surber, and Michael J. Kamdar co-founded the enterprise on May 27, 2011, and its corporate headquarters are situated in Boston, Massachusetts.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of Avalyn Pharma Inc. Common Stock, its business model, key products, and controversies.